SEARCH 
COMPANIES
Discover the reality of companies and brands!
www.eldemex.com
Free and independant information on large corporations

Pfizer, Inc.

Headquarters : 235 East 42nd Street New York, NY 10017 United States of America United States of America web www.pfizer.com tel. 212 573-2323 stock : PFE analytics

Brands

name
click to compare prices
? Shop local, ethical and at the best price on Ethishop

? Ethical ? rating of Pfizer, Inc. , group and subsidiaries

Human 1 Jobs -16% /1998 Pollution 10 Fraud 8 Offshore 16 Sales 48 Bn $.€ /year Profit 86 Bn $.€ /1998 Wage 2167 *min. Influence 27 Infocom 13
[click on the rating for the method or on the number for the data]

year
business
source
2006Pfizer manufactures 8,2% of the drugs consumed in the world, largest world maker.Les Echos
2005World's largest pharmaceutical company.Les Echos
2004In 2004, five drugs (Lipitor, Norvasc, Zoloft, Celebrex, Neurontin) make 47% of the company's sales et more than 2 billion US$ each. 10 drugs (Lipitor, Norvasc, Zoloft, Celebrex, Neurontin, Zithromax, Viagra, Zyrtec, Bextra, Xalatan) make 61% of its sales and more than 1 billion US$ each.
2004Pfizer sells 26% of the tobacco substitutes bought in France.Les Echos
2003Pfizer produces 6% of the drugs bought in JapanLes Echos
subsidiarycountry%source
NicOx France2,86
Pharmacia Corp. United States of America100L'Expansion
Warner Lambert Co. United States of America100
Wyeth United States of America100Cercle Finance
? More subsidiaries of Pfizer, Inc.
country
address & contact : production type
incentive source
Netherland Antilles Netherland Antilles
Pfizer Antilles Holdings N.V :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Netherland Antilles Netherland Antilles
Pfizer Antilles Holdings N.V. :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Bermuda Bermuda
The Kodiak Company Ltd :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Bermuda Bermuda
The Kodiak Company Ltd :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
China China
PharmaValley, Shanghai : R&D
 Les Echos
Costa Rica Costa Rica
Pfizer Zona Franca S.A :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Costa Rica Costa Rica
Zona franca Ultrapack & 2932345 :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Procomer
Costa Rica Costa Rica
Pfizer S.A :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Costa Rica Costa Rica
Pfizer S.A :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Gibraltar Gibraltar
Caribe Searle (Gibraltar) Limited :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Isle of Man Isle of Man
Pfizer Commercial Holdings Limited :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Isle of Man Isle of Man
Pfizer Ringaskiddy Production Company :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Isle of Man Isle of Man
Pfizer Commercial Holdings Limited :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Isle of Man Isle of Man
Pfizer Chemical Corp. Ltd :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Isle of Man Isle of Man
Pfizer Chemical Corp. Ltd :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Isle of Man Isle of Man
Pfizer Ventures Limited :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Isle of Man Isle of Man
Pfizer Ringaskiddy Production Co :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Isle of Man Isle of Man
Pfizer Pharmaceuticals Production Corporation Ltd :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
India India
Duchem Laboratories Limited :
 
Ireland Ireland
Dublin : R&D
Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Les Echos
Ireland Ireland
Pfizer Service Company :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Ireland Ireland
Pfizer Pension Trustees (Ireland) Limited :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Ireland Ireland
Pfizer International Holdings Limited, Dublin :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Ireland Ireland
Pfizer International Holdings Limited :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Ireland Ireland
Pfizer International Bank Europe :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Ireland Ireland
Pfizer Export Company :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Ireland Ireland
Pfizer Pharmaceuticals Production Corporation (partnership) :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Ireland Ireland
Pfizer International Bank Europe, Dublin :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Ireland Ireland
Pfizer Distribution Company :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Ireland Ireland
Pfizer (Ireland) Limited :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Ireland Ireland
Pfizer Holdings Europe :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Jersey Jersey
Pfizer Pharmaceuticals Jersey Ltd :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Jersey Jersey
Pfizer Pharmaceuticals Jersey Limited :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Jersey Jersey
Pfizer Ventures Limited :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Malaysia Malaysia
Pfizer Sendirian Berhad :
 
Panama Panama
Pfizer Corporation :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Panama Panama
Harmag, Inc :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Panama Panama
Pfizer Corporation :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Panama Panama
Harmag, Inc :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Panama Panama
Pfizer Pharmaceuticals Production Corporation :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Panama Panama
Pfizer International Corporation :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Philippines Philippines
Pfizer, Inc :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Philippines Philippines
Pfizer, Inc :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Singapore Singapore
SmithKline Beecham Animal Health Private Ltd. :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Switzerland Switzerland
AMS Medical Systems AG :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Switzerland Switzerland
Pfizer A.G :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Switzerland Switzerland
AMS Medical Systems AG :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Switzerland Switzerland
Pfizer A.G :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Thailand Thailand
Capsugel (Thailand) Ltd :
 
Turkey Turkey
:
 US Government Country Business Profile
Zimbabwe Zimbabwe
A.S. Ruffel (Private) Limited :
 

year name
photo position; compensation
source
2006Kindler, Jeffrey
See the photo of: Kindler, Jeffrey Chief Financial Officer;
2006McKinnell, Henry A
See the photo of: McKinnell, Henry A Chief Executive Officer; allowances: 180 million US$;
Les Echos
2002McKinnell, Henry A
See the photo of: McKinnell, Henry A Chief Executive Officer; salary: 10,54 million US$;
2002Shedlarz, David
See the photo of: Shedlarz, David Chief Financial Officer; salary: 4,14 million US$;
2001McKinnell, Henry A
See the photo of: McKinnell, Henry A Chief Executive Officer;
2000Burt, Robert N
See the photo of: Burt, Robert N Director;
2000Gray III, William H
See the photo of: Gray III, William H Director;
2000Howell, William R
See the photo of: Howell, William R Director;
2000Lorch, George A
See the photo of: Lorch, George A Director;
1998Mead, Dana G
See the photo of: Mead, Dana G Director;
1998Raines, Franklin D
See the photo of: Raines, Franklin D Director;
1998Steere Jr,
See the photo of: Steere Jr, Chief Executive Officer; salary: 3,96 million US$; stock-options: 21,01 million US$;
1997Cornwell, W Don
See the photo of: Cornwell, W Don Director;
1997McKinnell, Henry A
See the photo of: McKinnell, Henry A Director;
1997Simmons, Ruth J
See the photo of: Simmons, Ruth J Director;
1996Brown, Michael S
See the photo of: Brown, Michael S Director;
1996Kamen, Harry P
See the photo of: Kamen, Harry P Director;
1993Horner, Constance J
See the photo of: Horner, Constance J Director;
1990Ikenberry, Stanley O
See the photo of: Ikenberry, Stanley O Director;
1988Burns, M Anthony
See the photo of: Burns, M Anthony Director;
1987Steere, William C
See the photo of: Steere, William C Director;
1980Valles, Jean-Paul
See the photo of: Valles, Jean-Paul Director;
year
employees
<>
social impact : country
source
2009
-20000
Merger/Acquisition: With the takeover of Wyeth, Pfizer expects to achieve about $4 billion in "synergies" by 2012, enabling it to reduce the combined workforce of the two companies by 15%, or some 20,000 jobs. Pfizer announced that it will eliminate 8,000 jobs, 10% of its workforce. It is closing five of its 46 manufacturing plants.:
Business Week
2009
-800
Internal restructuring: Pfizer cuts 800 research positions in 2009 as part of a restructuring.: United States of America
Reuters
2008
-982
Internal restructuring: Pfizer cuts 743 medical representatives jobs and 200 jobs at its French headquarters.: France
AFP
2008
-275
Internal restructuring: Pfizer cuts 275 jobs from its manufacturing operations in Kalamazoo County, as part of "ongoing efforts to remain globally competitive". "We're restructuring many of our support staff, supervisory and operational functions in Kalamazoo manufacturing," the company spokesman said.: United States of America
2008
-500
Internal restructuring: Pfizer cuts half of its manpower of medical representatives to physicians in France (- 400 jobs), and a quarter of its medical representatives to the hospitals and specialist physicians. According to a trade union, this plan aims at improving the net margin, the ratio net profit on sales, currently at 28% to 35% in 2010.: France
Les Echos
2008
-219
Relocation: Pfizer delocalizes the manufacture of veterinary products of Amboise (Indre and the Loire) to Brazil. 10% of manpower of the factory are threatened. In addition, the research and development center of Tours is closed with 149 layoffs.: France
Les Echos
2007
-10000
Internal restructuring: Pfizer cuts 20% of its medical representatives in Europe, closes three research centers in the United States, one in Japan and another one in France, Amboise.:
Les Echos
2006
-2200
Internal restructuring: United States of America
L'Expansion
2006
-45
Internal restructuring: Restructuration du laboratoire de R&D d'Amboise.: France
Les Echos
2005
-750
Internal restructuring: Reestructuraci?n de su plantilla de Barceloneta y Arecibo.: Puerto Rico
El Vocero
2005
-500
Closure/Bankruptcy: Pfizer has announced plans to close its factory in Stockholm, will lead to the loss of 500 jobs over the next three years.: Sweden
The local
2005
-400
Internal restructuring: United Kingdom
La Tribune
2004
-509
Les Echos
2004
115000
2003
-300
Closure/Bankruptcy: Fermeture du si?ge social de sa filiale fran?aise: France
Les Echos
2003
-285
Closure/Bankruptcy: Fermeture du centre de recherche de Fresnes sp?cialis?e dans les allergies et les maladies respiratoires.: France
Les Echos
2003
-2200
AP
2002
98000
2001
90000
2000
90000
1998
46400
year
employees
<>
social impact : country
source
 21 informations, access to subscribers
year
country : consequences
source
2007Nigeria Afrik.com
2005United States of America brand: Bextra : Retir? du march? sur d?cision de la FDA en raison d'effets secondaires dangereux, sur la peau et le pression art?rielle notamment. En septembre 2009, Pfizer paye une amende de 1 milliard pour r?gler ? l'amiable le proc?s civil et 1,3 milliard de dollars pour solder le proc?s p?nal.Les Echos
2005brand: Geodon : Older patients with dementia who are given antipsychotic medicines are far more likely to die prematurely than those given placebos. Most died of heart-related problems like heart failure or infections like pneumonia (FDA)New York Times
2004United States of America brand: Celebrex : Une plainte en nom collectif contre Pfizer pour avoir publi? des communiqu?s "trompeurs" sur l'innocuit? de ses anti-inflammatoires Celebrex et BextraAFP
2004United States of America : 171 611 personnes contamin?es ? l'amiante par Quigley, une filiale de PfizerLes Barons Marqu?s
2004United States of America : A accept? de payer 240 millions de dollars de dommages et int?r?ts pour avoir conseill? son anti-?pileptique pour d?autres types de maladies que l??pilepsie, tels que la migraine, alors que la FDA ne lui avait pas accord? ce droit.Firstinvest
2004Canada brand: Celebrex : Celebrex accus? d'avoir caus? 14 d?c?s, 19 crises cardiaques et une centaine de r?actions n?gativesLe Bulletin des agriculteurs
2001United States of America : Plainte en nom collectif d?pos?e au tribunal de New-York par 30 familles nig?rianes victimes des essais cliniques du Trovan, un antibiotique contre la m?ningite. Au cours de cette ?tude, pratiqu?e en 1996 pendant une ?pid?mie de m?ningite, onze enfants sur deux cents avaient trouv? la mort et plusieurs autres avaient gard? de graves s?quelles c?r?brales ou motrices.Le Monde Diplomatique
1998United States of America : Pfizer manufactured defective cardiac valves which killed 165 patients.The Observer
year
country : description
1996Nigeria : Exp?riences cliniques men?es sans le consentement des patients ? Kano. De nombreux enfants morts ou handicap?s.Arte

yearfinancial misdemeanorsalesincome buybacksource
2008   48,38,1   billion US$Les Echos
2007   48,418,14   billion US$Les Echos
2006   48,419,33   billion US$Les Echos
2005   47,418,09   billion US$Les Echos
2005   5billion US$
2005   5billion US$
2005 Rapatriement de 3-,9 milliards de dollars de b?n?fices nets accumul?s hors des Etats-Unis, non impos?.     Les Echos
2004   52,5211,36   billion US$Les Echos
2004   5billion US$
2004 P?nalit? de 430 milions dollars pour fraude, promotion de Neurontin "off-label"     Les Echos
2003   44,743,91   billion US$
2002   32,379,13   billion US$
2001   32,267,79   billion US$
2001   5billion US$Boursier.com
2000   29,573,73   billion US$
1999   16,23,18   billion US$
1998   13,543,35   billion US$
1998   5billion US$SmartMoney
yearfinancial misdemeanorsalesincomeassetsbuybacksource
 18 informations, access to subscribers
year
purpose : intermediary/lobby : institution
source
2004Prevent binding environmental regulations (environmental protection through economic growth, self-regulation and free trade) : WBCSD (World Business Council for Sustainable Development) : : United Nations translateWBCSD
2001Access to foreign market (through MAI, WTO, GATS), prevent binding environmental regulations : USCIB (US Council For International Business) : : US Government translateUSCIB
2000Limit the legal liability, no price control, no list of preferred drugs, hampers the approval and marketing of generic drugs, no drug imports, no limit to drug advertising? : Pharmaceutical Research and Manufacturers of America : : US government, congress, senate translateWashington Post
2000Investment protection and market access (to Mexico and Canada through NAFTA), to Latin America (through FTAA). : Business Roundtable : : US government, senate, congress translateCenter for Responsive Politics
2000Lift the ban on bovine growth hormons, the moratorium on GMOs : EFPIA (European Federation of Pharmaceutical Industry Associations) : : European Commission translateEFPIA
2000Prevent binding regulation, co- or self-regulation instead. : American Chamber of Commerce's EU Committee : : European Commission translateCorporate Europe Observatory
2000lift the ban on bovine growth hormon : FEDESA : : European Commission translateFedesa
1999Protection of Intellectual Property -TRIPS Agreement : Intellectual Property Committee : : WTO translateCorporate Europe Observatory
1999Market admission for genetically modified organisms : EuropaBio : : European Commission translateCorporate Europe Observatory
1999Market access and investment protection (through WTO, GATS), avoid social and environmental rules : ICC (International Chamber of Commerce) : : WTO, GATS translateCorporate Europe Observatory
1999Deregulation and "maximum liberalization" through WTO, GATS : TABD (Transatlantic Business Dialogue) : : US Government / European Commission translateCorporate Europe Observatory
1998Regulation favorable to company's interests : Contribution to Candidate's Political Action Committee : amount: 302 thousand US$ : US President, Congress, Senate translateCenter for Responsive Politics
1997Legislation favorable to company's interests : Direct donation : amount: 10000 thousand US$ : US President, Congress, Senate translateCenter for Responsive Politics
1997Legislation favorable to company's interests : Direct donation : amount: 733 thousand US$ : US President, Congress, Senate translateCenter for Responsive Politics
? More influence from Pfizer, Inc.
? Influence in 2007
year
purpose : intermediary/lobby : institution
source
 14 informations, access to subscribers
? More influence from Pfizer, Inc.
? Influence in 2007
yeardonatorcountryamountsource
2003State of MichiganUnited States of America635 million US$AP
yeardonatorcountryamountsource
 1 informations, access to subscribers
year
dubious practice : image
source
2008Disinformation: "To boost sales of the anti-depressant Zoloft, Pfizer sought to expand the potential market by commissioning studies that suggested that the disorder PTSD was not as rare as most believed. A group called the PTSD Alliance. PTSD is Post Traumatic Stress Disorder. And one of the main messages of this group was that five percent of the American public suffered from PTSD. And this is estimate was millions and millions more than the government actually said suffered from this illness. And later, I learned that this group wasn't actually what I thought it was. It was the creation of a public relations firm working for Pfizer to sell more Zoloft.": PBS
2008"Documents and emails released this week ... suggest Pfizer's marketers influenced" research on the drug Neurontin "by declining to release or altering the conclusions of studies that found no beneficial effect from Neurontin for various off-label conditions," reports Keith Winstein. The Food and Drug Administration approved Neurontin for epilepsy and shingles. In 2004, Pfizer's Warner-Lambert unit admitted to promoting "off-label" uses. Companies can't promote drugs for unapproved uses, though doctors can prescribe off-label. Pfizer paid $430 million for the offense and claimed it ensured "there was no improper marketing after it purchased Warner-Lambert in 2000." But the new documents, which were submitted in a lawsuit against Pfizer, detail more recent attempts to boost off-label sales. After one study showed Neurontin didn't lessen diabetic nerve pain, a marketer suggested "delaying the publication for as long as possible." One researcher emailed that she was told "not to publish anything that damages Neurontin's marketing success." Pfizer also failed to publish results that Neurontin didn't ease post-operative nerve pain. Lastly, after the drug was shown to have no effect on bipolar disorder, a Pfizer consultant writing up the study excluded 16 patients and changed how other patients were characterized, thus "turning a failure into a success.": Wall Street Journal
2007Disinformation: In early September, "major newspapers reported the alarming news that suicides among young people were on the rise because of a precipitous drop in the use of antidepressants," writes Alison Bass. The academic study the news articles were based on concluded that new safety warnings for young people using antidepressant drugs had discouraged doctors from writing prescriptions for depressed youths. But there's a hole in that argument: "while there was indeed an upturn in suicide rates among youths ... the number of prescriptions for antidepressants in the same age group remained basically unchanged." Bass points out that the pharmaceutical companies that make antidepressants might "benefit from the latest alarm about an apparent upturn in youth suicide rates. ... These companies have an enormous stake in reversing the current FDA warnings." Pfizer, which makes the antidepressant Zoloft, did provide $30,000 for the academic study, and the study's lead authors have ties to Pfizer, GlaxoSmithKline and Wyeth Pharmaceuticals. "This isn't the first time that suicide rates have been trotted out as a public relations weapon," Bass adds. "Proponents of psychotropic drugs have long argued that suicide rates ... fell after" such drugs were introduced, though the decline began well before the drugs were widely prescribed.: Boston Globe
2006Disinformation: Pfizer broadcasted a video news release (VNR), a fake TV news, on cable channel KPIX-5, without disclosure.: PR Watch
2006Biopiracy - Appropriation of public knowledge: Pfizer sues the Philippines to prevent it from producing a generic version of its drug, in spite of the international authorization of the agreements on the intellectual property (TRIPS).: AFP
2006Disinformation: Pfizer hired C&W PR group "for general representation and issues concerning Medicare/Medicaid and pharmaceutical research & development." The 11-person team assigned to the account includes former Minnesota Republican Congressman, Vin Weber. Weber is also Chairman of the National Endowment for Democracy and a board member of both the Aspen Institute and Citizens Against Government Waste. He was also involved with the neo-conservative network, the Project for a New American Century. In mid-June two men announced they were suing Pfizer, alleging serious side effects from the anti-cholesterol drug Lipitor.: public relations: CPR Watch
2005Arguable partnership: Sharing the Care: "Pfizer donates its most advanced medicines to low-income, uninsured patients through a network of more than 380 federally-qualified health centers": value: Health partner;
2005Arguable partnership: Partnership for Prescription Assistance with the American Academy of Family Physicians, American Academy of Physician Assistants, American College of Emergency Physicians, NAACP, National Alliance for Hispanic Health, National Alliance for the Mentally Ill, National Association of Chain Drug Stores, National Medical Association, National Urban League, United Way of America.: value: Health;
2005Disinformation: Sponsor of the Business for Social Responsibility's 2005 conference.: PR Watch
2005Arguable partnership: Connection to Care: "medicines reach patients in need through individual physicians' offices": value: Health partner;
2004Disinformation: In December 2004 a report linked high doses of Celebrex, a member of the class of drugs referred to as Cox-2 inhibitors, to an increased risk of heart attacks. The co-managing director of the WPP Group's health and medical practice, Sherry Pudloski, told O'Dwyer's PR Daily that they still had the account but declined to talk about what they did for Pfizer.: Sourcewatch
2004In November 2004 Ogilvy Public Relations Worldwide - a part of the WPP Group - took over the accounts for both of Pfizer's Celebrex and Bextra pain medications.: Sourcewatch
2004Arguable partnership: Don pour les victimes du tsunami: 10000000 de dollars: value: Humanitaire;
2001ad budget: 992 million US$; Advertising Age
2000ad budget: 944 million US$; Advertising Age


Bookmark and Share    en espa?ol  en fran?ais  in italiano
translate this page in arabic chinese dutch german japanese korean russian
Legal notice ? T&C 1999-2010
 CONTRIBUTIONS
日本熟妇高清无码视频_日本熟妇中文字幕无码_日本熟妇熟色在线观看中文